Pettyjohn, Wood & White, Inc Amgen Inc Transaction History

Pettyjohn, Wood & White, Inc

$502 Million
Q1 2024

A detailed history of Pettyjohn, Wood & White, Inc transactions in Amgen Inc stock. As of the latest transaction made, Pettyjohn, Wood & White, Inc holds 2,622 shares of AMGN stock, worth $815,127. This represents 0.15% of its overall portfolio holdings.

Number of Shares

2,622

Previous 2,572 1.94%

Holding current value

$815,127

Previous $740,000 0.68%

% of portfolio

0.15%

Previous 0.16%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $13,443 - $16,228	50 Added 1.94%	2,622 $745,000
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $75,871 - $94,196	347 Added 15.6%	2,572 $691,000
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $32,140 - $38,005	150 Added 7.23%	2,225 $493,000
Q1 2023 Apr 25, 2023	BUY	$225.79 - $275.2 $18,740 - $22,841	83 Added 4.17%	2,075 $501,000
Q4 2022 Feb 02, 2023	SELL	$229.03 - $291.01 $11,451 - $14,550	-50 Reduced 2.45%	1,992 $523,000

Q3 2022 Oct 28, 2022	SELL	$224.46 - $253.15 $2,244 - $2,531	-10 Reduced 0.49%	2,042 $460,000
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $2,307 - $2,567	10 Added 0.49%	2,052 $499,000
Q1 2022 Apr 22, 2022	SELL	$219.27 - $242.57 $26,750 - $29,593	-122 Reduced 5.64%	2,042 $494,000
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $14,120 - $16,159	-71 Reduced 3.18%	2,164 $487,000
Q3 2021 Nov 08, 2021	SELL	$212.27 - $248.7 $10,613 - $12,435	-50 Reduced 2.19%	2,235 $475,000
Q2 2021 Aug 03, 2021	SELL	$233.58 - $259.14 $80,585 - $89,403	-345 Reduced 13.12%	2,285 $557,000
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $78,999 - $92,061	-356 Reduced 11.92%	2,630 $654,000
Q4 2020 Feb 04, 2021	SELL	$216.38 - $257.67 $8,006 - $9,533	-37 Reduced 1.22%	2,986 $687,000
Q3 2020 Oct 26, 2020	BUY	$234.65 - $260.95 $12,436 - $13,830	53 Added 1.78%	3,023 $768,000
Q1 2020 Apr 20, 2020	SELL	$182.24 - $241.7 $11,845 - $15,710	-65 Reduced 2.14%	2,970 $602,000
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $23,651 - $30,400	-125 Reduced 3.96%	3,035 $732,000
Q3 2019 Nov 04, 2019	BUY	$174.11 - $208.62 $67,380 - $80,735	387 Added 13.96%	3,160 $612,000
Q1 2019 Apr 26, 2019	SELL	$180.87 - $203.88 $50,281 - $56,678	-278 Reduced 9.11%	2,773 $527,000
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $18,529 - $20,889	100 Added 3.39%	3,051 $632,000
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $95,478 - $107,243	-575 Reduced 16.31%	2,951 $545,000
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $518,286 - $605,682	-3,059 Reduced 46.45%	3,526 $601,000
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $105,493 - $117,868	-625 Reduced 8.67%	6,585 $1.15 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $1.21 Million - $1.38 Million	7,210	7,210 $1.34 Million

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pettyjohn, Wood & White, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pettyjohn, Wood & White, Inc with notifications on news.

Account

Pettyjohn, Wood & White, Inc Amgen Inc Transaction History